Leslie Holsinger
Executive Vice President of Research and Development
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Quince Therapeutics, Inc. (QNCX)
Proxy statement
Start not stated–2022-07-31
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Quince Therapeutics, Inc. (QNCX) | Former Executive Vice President of Preclinical Development | $247,297 | $3,236,125 |
| 2021 | Quince Therapeutics, Inc. (QNCX) | Former Executive Vice President of Preclinical Development | $430,000 | $603,850 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.